Why the study?
Intracranial aneurysms and abdominal aortic aneurysms lack preventive drug therapies and share molecular features, but whether their molecular commonality lies preferentially in rupture rather than formation had not been directly addressed.
Population
Eight human transcriptomic series of intracranial and abdominal aortic aneurysms
Comparison
Rupture-associated transcriptional concordance (ruptured vs unruptured) vs formation-associated concordance (aneurysm vs control)
Design
Cross-bed transcriptomic, genetic, and pharmacologic analysis
Answers are grounded in this paper and cite their sources.
Does not support shared rupture signatures for risk stratification; leaves open bed-specific preventive targets.
Background/Objectives: No drug prevents an intracranial aneurysm (IA) or an abdominal aortic aneurysm (AAA) from rupturing. The two diseases share molecular features, but whether that commonality lies preferentially in rupture—the transition a preventive treatment must avert—has not, to our knowledge, been addressed directly. We therefore examined whether rupture-associated transcriptional changes exhibit greater cross-bed directional concordance than formation-associated changes. Methods: Across eight human transcriptomic series, we compared cross-bed directional concordance for rupture (ruptured versus unruptured) and formation (aneurysm versus control) using a prespecified difference standardized against a signal-free joint specimen-level permutation null. Replication, co-expression organization, classifier transportability, functional enrichment, human genetic evidence, and pharmacologic tractability were examined as distinct evidence domains, supplemented by conditional simulations of signal-to-noise asymmetry and sensitivity analyses of cross-platform classifier transfer. Results: Preferentially greater rupture-associated concordance was not demonstrated: at the gene, gene-set, and program levels, all three point estimates favored formation, but none of the one-sided tests supported the prespecified rupture-favoring alternative (Holm-adjusted p = 1.0000). A reproducible rupture-associated component nonetheless remained: 459 of 1115 concordant genes measurable in all three independent IA validation cohorts retained their direction in each. Rupture-associated modules were variably preserved, and classifiers lost discrimination on transfer between IA and AAA cohorts profiled on different platforms. Only collagen-related enrichment remained significant under the measurable-gene background specification. Genetic estimates were obtainable for five of 63 prioritized genes, but none met the prespecified support criteria; documented pharmacologic actions both opposed and reinforced rupture-associated expression. Conclusions: Shared transcription, conserved organization, human genetic support, and pharmacologic direction were distinct properties of the rupture-associated signal. Preventive target selection should preserve these distinctions rather than allow cross-bed transcriptional concordance to stand in for evidence it does not provide.
No takes yet. Share an insight, caveat, or question.
Tamdoğan et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: